ConCallIQ
Go Pro
NATHBIOGENES Diversified 15 May 2026

Nath Bio-Genes Ltd — Q4 FY26

Nath Bio-Genes delivered a strong FY26 with revenue of ₹431.6 crore, up 19% YoY, driven by robust volume growth across cotton (+22%), paddy (+25%), and maize (+54%).

bullish high
Compare with...
Revenue ₹52 Cr +19%
EBITDA ₹53 Cr
PAT ₹-0 Cr -8%
EBITDA Margin 8.68%
Duration 50 min
Read Time 1 min read

✓ Verified against BSE filing

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

El Niño impact on crop patterns

Analyst raised concern; management acknowledged potential delays in sowing but believes diversified portfolio and geography mitigate risk.

medium · analyst_question
R

Inventory buildup and working capital strain

Inventory increased to ₹113 crore due to higher cotton production; management expects liquidation over 2 years but carries carrying cost risk.

medium · data_observation
R

Gross margin normalization

Gross margin fell from 63% to 56% due to product mix; management expects it to stabilize around 53-54%, limiting profit growth.

medium · management_commentary
R

Uzbekistan JV execution risk

First-year revenue of ₹15 crore is small; management declined to give targets, citing need for more field data.

low · analyst_question